Eterna Therapeutics Inc Com (New) Skyrocketed

Eterna Therapeutics Inc Com (New) (ERNA:NASDAQ) jumped higher at $0.64, a gain of 35.4%. On Wed, Jan 22, 2025, ERNA:NASDAQ hit a New 2-Week High of $0.64. The stock got featured on our News Catalysts scanner on Tue, Jan 14, 2025 at 09:32 AM in the 'BIOTECH' category. From Fri, Jan 10, 2025, the stock recorded 71.43% Up Days and 37.50% Green Days
The stock spiked on Tue, Jan 14, 2025 at $0.96 with a volume of 576M+.
About Eterna Therapeutics Inc Com (New) (ERNA:NASDAQ)
Brooklyn ImmunoTherapeutics Inc is a clinical-stage biopharmaceutical company. It is developing IRX-2, a novel hd-IL-2 -based therapy, to treat patients with cancer.
Top 10 Gainers:
- Asset Entities Inc. (ASST:NASDAQ), 51.11%
- Jayud Global Logistics Limited (JYD:NASDAQ), 42.51%
- Mobix Labs Inc. (MOBX:NASDAQ), 40.68%
- LatAmGrowth SPAC (LATG:NASDAQ), 40%
- Eterna Therapeutics Inc Com (New) (ERNA:NASDAQ), 35.44%
- Tonix Pharmaceuticals Holding Corp. (TNXP:NASDAQ), 33.53%
- Rekor Systems, Inc. (REKR:NASDAQ), 32.48%
- PTL LTD (PTLE:NASDAQ), 31.69%
- ImmunoPrecise Antibodies Ltd. (IPA:NASDAQ), 30.73%
- Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ), 29.87%